These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27 related articles for article (PubMed ID: 6345831)
1. Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer. Bouchelouche K; Capala J; Oehr P Curr Opin Oncol; 2009 Sep; 21(5):469-74. PubMed ID: 19535981 [TBL] [Abstract][Full Text] [Related]
2. Capromab pendetide. A review of its use as an imaging agent in prostate cancer. Lamb HM; Faulds D Drugs Aging; 1998 Apr; 12(4):293-304. PubMed ID: 9571393 [TBL] [Abstract][Full Text] [Related]
3. Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model system. Goldenberg DM; Sharkey RM; Primus FJ; Mizusawa E; Hawthorne MF Proc Natl Acad Sci U S A; 1984 Jan; 81(2):560-3. PubMed ID: 6582510 [TBL] [Abstract][Full Text] [Related]
4. Is there a role for radioimmunolocalization in diagnosis of intracranial malignancies?: discussion paper. Kemshead JT; Jones DH; Goldman A; Richardson RB; Coakham HB J R Soc Med; 1984 Oct; 77(10):847-54. PubMed ID: 6492045 [No Abstract] [Full Text] [Related]
5. Radioimmunolocalization of human brain tumours: biodistribution of radiolabelled monoclonal antibody UJ13A. Richardson RB; Davies AG; Bourne SP; Staddon GE; Jones DH; Kemshead JT; Coakham HB Eur J Nucl Med; 1986; 12(7):313-20. PubMed ID: 3792360 [TBL] [Abstract][Full Text] [Related]
6. Localization of human sarcoma with radiolabeled monoclonal antibody. A preliminary study. Greager JA; Brown JM; Pavel DG; Garcia JL; Blend M; Das Gupta TK Cancer Immunol Immunother; 1986; 23(2):148-54. PubMed ID: 3779715 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma. Abdel-Nabi HH; Ortman-Nabi JA; See W; Lee J; Ireton R; Boileau M; Unger MW; Halverson C Eur J Nucl Med; 1990; 16(3):149-56. PubMed ID: 2364957 [TBL] [Abstract][Full Text] [Related]
10. Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging. Goldenberg DM; DeLand FH; Bennett SJ; Primus FJ; Nelson MO; Flanigan RC; McRoberts JW; Bruce AW; Mahan DE JAMA; 1983 Aug; 250(5):630-5. PubMed ID: 6345831 [TBL] [Abstract][Full Text] [Related]
11. Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase. Goldenberg DM; DeLand FH Urol Clin North Am; 1984 May; 11(2):277-81. PubMed ID: 6328719 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo. Leroy M; Teillac P; Rain JD; Saccavini JC; Le Duc A; Najean Y Cancer; 1989 Jul; 64(1):1-5. PubMed ID: 2731106 [TBL] [Abstract][Full Text] [Related]
13. [Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging]. Hao XK Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):655-7, 700. PubMed ID: 7510212 [TBL] [Abstract][Full Text] [Related]
14. Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase. Ahonen A; Kairemo K; Karnani P; Heikkilä J; Nurmi M; Teräs M; Lukkarinen O Acta Oncol; 1993; 32(7-8):723-7. PubMed ID: 8305218 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunodetection of prostatic cancer: in vivo use of antibody against r-seminoprotein for diagnosis of prostatic cancer. Hao XK; Liang GD; Zhang YH; Sun BZ; Zhou ZY; Han JL; Wan HL; Liu WS Chin Med J (Engl); 1993 May; 106(5):348-50. PubMed ID: 7691485 [TBL] [Abstract][Full Text] [Related]